Heron Therapeutics, Inc.

NASDAQ:HRTX

1.88 (USD) • At close May 30, 2025
Bedrijfsnaam Heron Therapeutics, Inc.
Symbool HRTX
Munteenheid USD
Prijs 1.88
Beurswaarde 286,820,320
Dividendpercentage 0%
52-weken bereik 1.04 - 3.93
Industrie Biotechnology
Sector Healthcare
CEO Mr. Craig Alexander Collard
Website https://www.herontx.com

An error occurred while fetching data.

Over Heron Therapeutics, Inc.

Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It

Vergelijkbare Aandelen

HilleVax, Inc. logo

HilleVax, Inc.

HLVX

1.87 USD

Absci Corporation logo

Absci Corporation

ABSI

2.65 USD

ALX Oncology Holdings Inc. logo

ALX Oncology Holdings Inc.

ALXO

0.486 USD

BioXcel Therapeutics, Inc. logo

BioXcel Therapeutics, Inc.

BTAI

1.18 USD

Fulcrum Therapeutics, Inc. logo

Fulcrum Therapeutics, Inc.

FULC

6.875 USD

C4 Therapeutics, Inc. logo

C4 Therapeutics, Inc.

CCCC

1.25 USD

Athira Pharma, Inc. logo

Athira Pharma, Inc.

ATHA

0.313 USD

OraSure Technologies, Inc. logo

OraSure Technologies, Inc.

OSUR

2.88 USD

EyePoint Pharmaceuticals, Inc. logo

EyePoint Pharmaceuticals, Inc.

EYPT

7.24 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)